Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, one has to understand frustration of formerly positive sahreholder: Dufflied by himself states at one of his newsletters, that he appreciated those shareholder who kept confidence over the last ten (10!!!) years in the technology of Plandai. With clear words: Plandai does not work on extraction since 2012 - they work on it since 2003/2004.
Let us get real: The 'biotechnology' of Plnadai does not have the same quality and demands like those biotechnical products which need the confirmation and permissionm by the FDA. Products, extractions methods etc. of the Plandai is MUCH easier and much more simple than usual biotechnical developments with thousands of clinical reports, proves, etc.
I have studied medicine and have a bit a clue about the product of Plandai. I do not get at all why it should have taken ten years to come to the result that FDA approval is not needed for this extraction products.
For those, who have a bit of understanding for such products, this whole last two years must be a joke - at least regarding the clinical reports, maybe not regarding of the facilities.
However, keeping confidence demands to forget Plandai for some years and avoid to listen to the big wordings and promises of Duffgield since 2011/2012 - and it demands to ignore the amazing salaries Duffield pays to himself - even the company does not produce anything yet but debt!
However, Doffield found his golden egg with PLPL - wondering if shareholder ever find more than pennies here.
Well, PLPL is nothing but a high risk non-revenue penny - since two years and still.
Nothing yet to be thrilled about.
Have to confirm, this information sounds good.
NEWS: Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
NEW YORK, NY--(Marketwired - December 04, 2014) - Timing is everything and when Plandaí Biotechnology (PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did they know then that a Presidential runoff in that country would be of great interest today. Plandaí got the green light back in September from Uruguay's Minister of Public Health to collaborate with the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo.
Permission was granted to Plandaí by a government that has developed a plan to regulate the production, distribution and sale of marijuana nationwide. Uruguay's government under President Jose Mujica of the Broad Front Coalition was clearly friendly to the future of cannabis in that country, and Tabare Vazquez, also of the Broad Front Coalition, promised to continue the liberal cannabis policy.
But, in Sunday's election, a member of the opposition party promised to undo the plan. When the dust finally settled, the State-run cannabis plan survived as Vazquez, who is an oncologist, handily won the Presidency 53 percent to 40 percent.
This is, of course, good news to Plandaí's own plan which includes a collaboration that will allow Plandaí, through its wholly owned subsidiary Plandaí Biotechnology - Uruguay, SA, to grow cannabis in conjunction with the University of the Republic, for medical research, which will be conducted by students and scientists from the School of Science at the University.
Plandaí can continue with its plan to now legally grow cannabis, and not just CBD dominant strains of the plant. The company's plan then calls for clinical testing using the drug.
The first phase of the project will establish the infrastructure and protocols for growing the cannabis in a controlled environment to ensure genetic purity and chemical consistency.
Due to the ongoing controversy about the growth and availability of medicinal cannabis in many parts of the US, as well as the ability to conduct US testing on the medicinal effectiveness of cannabis, many patients who might benefit from using medicinal cannabis to treat a multitude of conditions cannot access it.
The approval for Plandaí to grow marijuana for medical research from the pro-cannabis government was issued this past September, and it is scheduled to take place over a 3-year period beginning in early 2015.
Plandaí's collaboration will allow it to test marijuana for medicinal properties, and it also affords the company the chance to provide a pure chemical extract for third party testing.
Roger Duffield, the company's CEO and President, said that the research will enable clinicians to set dosage parameters as well since, with clinical testing, Plandaí will have benchmarks for absorption and metabolization like it has established with its green tea extract.
A team of academics at the University of the Republic will collaborate with Plandaí's scientists, after the first phase is complete, to test the cannabinoid complex for potential benefit for treating neuron disorders, cancers and concussion injuries through animal testing.
When Plandaí is ready to conduct human clinical trials, the company will be required to seek prior approval from Uruguay's Ethics Committee and Medicine Council. With Vazquez winning the Presidency, this should benefit Plandaí's plan to further its own research and eventually lead to approval for human clinical trials.
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, CEO interviews and feature news articles. SMMG is compensated $3,500 per month by Plandai Biotechnology for content development. Previously, SMMG was compensated for similar content by a third party which occurred from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its content. Neither SMMG nor anyone associated with it owns shares in PLPL. For more information: www.stockmarketmediagroup.com.
My first thought was' A former Microsoft director = vicepresident at a pennystock like PLPL? Does he need this ?' than I changed my mind. But today I come back to this past thought and belive, Shively made tons of $ at Microsoft, moved on, thought legalization of pot might be something interesting - if you are bored by high society you thing thinks like this . and finally he shows his face everywhere in public - and that's what he loves. PLPL was just a little sidewards flip without any real function and value for him. This guy is for sure a dead duck - what else could he be after 3/4 of a year at Plandai without doing ANYTHING at this company. I even believe he is never present at the management - Duffield was happy to get this name and did hope for a PPS movemenet - which worked. And now it is dead. Shively has no value for PLPL and he does not anything to change this. Maybe he has had an accident and lost his tongue................ok, that would be an excuse !
tmonkey, I do not care anymore if management serve themselves with exxegareted salaries as long as REAL revenues will be made. Those revenues will move the shareprice which I am going to use to leave. A greedy management isn't noticed by stockmarket at the first - stockmarket is waiting for revenues and PPS always rocks with good numbers. Smart rule of speculations: Sell on good news ! I am just waiting for such good news, but I doubt they will be thrilling - the mouth of a pennystock CEO is always ten times bigger compared to the results after ten years. If PLPL will ever will be able to make those reveneues of 30 million per year - which Duffield did promise already in 2012 - we will write the year 2020. LOL Does anybody really intend ot stay another six years in PLPL ?!
Guess today we have an all-time-low volume!
I think confidence in a listed stock with endless delays, promises, non-active directors, and so on, is the hardest part. By taking into account that 99% of such listed penny start ups are scams fakes, zero-CEOs, useless products and unable managements, 'waiting' is the smallest problem IF a management has proved to be able to deliver. As Plandai did not deliver anything yet after so many years.....for what shall stockmarket member wait?! If Plandai does not deliver revenues again 4th Q. - which is clear anywait - shareholder have to wait another three months ....and maybe so on as Plandai will not be able to make millions within some months. Duffields has opened his mouth MUCH too wide in 2011/2012. No wonder most of PLPL shareholder have left the boat - which is right in my opinion. As I said, I am just here because I play with free shares.
My confidence is not very big, I just wait for a better PPS to get out and watch from the sideline if Plandai will ever make more then $ 2 million per year.
Plandai Biotech., Inc. deleted blog at their website ! Well, no wonder, the comments there got enormously negative about the company and the CEO, about empty promises, missing clinical results, missing revenues since years, etc.
READ: “Secret” technology turns local farm into green tea extract factory
See more at:
http://www.pub.ac.za/newsletter/02-201412/article-1.html#sthash.0pZFbDUR.dpuf
Thank you - before this important information we didn't exactly know how to assume this expection about Plandai.
Guess tax write off will increase the dynamic of this downtrend till end of 2014. However, the whole progress at Plandai is less than pleasant after 2 years of empty promises, a non-active Shively, and zero revenues still with endless debt. I assume some stil lbuy cause they hope for a hype in spring. But if Plandai goe .20 such a hyphe might push the pric e up to .35 / . 40 again - and that's it. Last but not least: I do not believe Plandai will be able to show a lot of reveneues already first quarter 2015. So the shareprice will stay low. This story got boring and I worry that stockmarket losses more and more interest in Plandai, followed by negative comments and finally the argument it is a scam.
Plandai is a big disappointment in my opinion.
This happens at all listed non-revenue-pennystock. I am not astinished - I would even wonder much more if Plandai ever goes over 1.5 again.
But for trader this is a useable stock...volatility within weeks and months which helpd to get in and out again and again. Unfortunately nothing for serious shareholder.
Ifchart technique would be useable here - which it isn't at all - I would said: Wait for real signals before getting in for a hold. But unfortunately there are no chart signals. So, as always - high risk with the chance to get out without too much losses ( excluded those who got in above 2.00 ...)
PS. I also could be wrong: My interpretation currently: sell-signal as we are below .35 again with a down trend again. Not to forget - it is just end of November - still a looong time till any revenues. Could get unpelasant before christmas when some sell for taking out their money as well as for tax reasons at every years end.
"SMMG is compensated $3,500 per month by Plandai Biotechnology for content development. Previously, SMMG was compensated for similar content by a third party (?) which occurred from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its content."
Well, Plandai wants to keep shareholder and stockmarket 'happy' without revenues all 2012/2013/2014. Amazing anyway that the stockprice stays above .30 = marketcap of $40.000.000 for ....selling timber for some thousand bucks LOL Amazing how this story keeps alive, other stocks would be .05 already.
News: Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
Marketwired - Plandai Biotechnology, Inc. November 18, 2014 9:00 AM
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the Pheroid® technology to further increase bioavailability in its products. This enhanced bioavailability allows Plandaí to offer a potential solution for many possible viral and infectious diseases.
Infectious diseases rely on glycoproteins that bind the virus to healthy cells or T-cells, which are a type of white blood cells that play a major role in protecting the body from infection. When the virus attaches, it enters into the healthy cell, taking its genetic material, replicating it, exhausting all the cells resources, killing the cell, and then exiting and repeating the process until the infected individual cell dies.
Several independent investigations have determined that the catechins found in green tea, namely epigallocatechin gallate or EGCG, bond more strongly to healthy cells than viruses do, which blocks them and prevents the virus from entering the white blood cells. Researchers at the Baylor School of Medicine and at Texas Children's Hospital have shown the ability of catechins to prevent binding of the virus protein to the white blood cells, but, of note, to be effective it requires an excessive dosage and a dosage with higher bioavailability. Because generic green tea extracts cannot deliver enough of the catechins into the bloodstream and then get those catechins absorbed by the white blood cells, the true effectiveness of catechins in preventing or treating viruses is not known.
For a drug or compound to have a therapeutic effect, it has to reach the site where it will take action in sufficient quantities. Which brings us back to Plandaí. Plandaí's green tea-based Phytofare™ Catechin Complex has already shown in a clinical trial performed at North West University in South Africa that it offers ten times greater bioavailability than a commercially available green tea extract. The Company is now further testing its product when enhanced by the Pheroid® delivery system. The Pheroid® entrapment system has been shown to enhance the absorption of various pharmacological compounds and biological molecules.
And this is where Plandaí's green tea extract could potentially offer hope as an anti-viral protection solution. For starters, according to Professor Anne Grobler of North West University who conducted the company's clinical trial, Plandaí's product showed that by using the company's extraction process, which uses live plant material, all 8 of the green tea plant's catechins, including EGCG, were present in the bloodstream versus only 2 catechins detected in the bloodstream when the commercial extract was tested.
Additionally, the trial's results found that when using the company's technology, absorption of those catechins was 5 times greater, and the life span of the catechin's molecules in the bloodstream was doubled in Phytofare™ when compared to that of the commercial green tea extract.
Now, with the use of the Pheroid® technology, Plandaí could likely offer an even more potent solution. The Pheroid® technology is an encapsulation or entrapment technology that encases the target material inside of a long-chain fatty acid.
In the case of many infectious diseases, the target cells (white blood cells) perceive the fatty acid as food and allow the Pheroid® to pass through the cell membrane which greatly enhances bioavailability, or absorption. The fatty acid also protects the entrapped material from damage and metabolization as it passes through the gastro-intestinal tract.
What this means is that the Pheroid® technology should allow the company to get its Phytofare™ extract to the target cells intact and fully functional directly to the target cells and potentially provide a simple, affordable and natural anti-viral solution.
.....................................................................
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, CEO interviews and feature news articles. SMMG is compensated $3,500 per month by Plandai Biotechnology for content development. Previously, SMMG was compensated for similar content by a third party which occurred from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its content. Neither SMMG nor anyone associated with it owns shares in PLPL. For more information: www.stockmarketmediagroup.com.
Shively is in PLPL since February - what for? An Ex-Microsoft director just to show off at PLPL? This guy is a dead duck.
Possible. Agree. Money to survive will be the main problem at PLPL. Those past delays could break companies neck as grwing debt could force dilutuion and dilution puts shareprice under pressure - so even more dilution could be possible.
However, with regards to the past two years, Plandai is not in a great situation end of 2014! Clincal results do not interest me - I speculate on a running company with real revenues - which is the speculation - otherwise it would be gambling. Until now PLPL was gambling. Curious how this goes on.
Nice you ask for my opinion - even it is just a personal opinion of course.
Predictions need facts and as long as a company does not delivery usueful busienss facts as long predictions have to be ridiculous.
Nevertheless 5 scenarios are possible IMO:
1. PLPL does not deliver pleasant business results or revenues, just new delays and useless news, the compnay will lose confidence in the stockamrket and inevstors/banks will not help anymore..........Ergo: price goes .15
2. PLPL also losses Shively.Ergo: most MJ fans will sell PLPL! price goes even below .15
3. PLPL delivers revenues above $ 5 million ....price might go .80 to 1.00
4. PLPL delivers revenues but dilutes because no further loans exist....price stays .50 to .60
5. PLPL delivery revenues and Shively - finally - moves his a&&....price might go 1.50
All in all, I do not believe PLPL is naything like a 10-bagger, I think the price range of this stock in 2015 will be between .50 and 1.80 - BUT ONLY if Plandai delievers a ready product, sales and revenues of some millions of $. But I doubt this, honestly said: IMO Pladnai might have revenues 1st Q of $250k, and the other quarters maybe some more. End of 2015 maybe all in all revenues of $ 1 to 1.5 million with tea extract (but for sure with nothing else - which is finally not enough for a great progress!) - AND, sorry, I believe debth will increase significantly by salaries and costs for production and clinical researcdh etc.etc.. That is the main reason why I do not believe in much highe stockprices.
Guess you are kidding. 10Q of today:
Revenues $26,380 ( for selling TIMBER !!!)
and the best joke: cost of this Sale: $ 160,057
And of course: increase of salaries.
What a great management of a running company. Question: Where is it running to? LOL
By the way: I predicted in early 2014 we will have no significant revenues in 2014 ... but I didn't know we will have negative revenues !
Obvious and visible criminality - but no justice! Strange democrathy regarding BGMO and Hillard Herzog. A SEC systems which obviously is a big failure with big words of no value.
Endless delays: now sales of products in december only. Will be a wonderful 10Q again - no wonder: 40.000 shares only traded today. Since long the worst volume ofr a traing day.
Well, I never have been in a microcap with a mc of $21.000. It sound so ridiculous that owners don't do anything with such a shell - I am sure: the ground this companie purchases is a sheel as well... no gold at all. How should they be able to pump this 'story' well as long as they only can pump ground water LOL
...and I think it is important to notice that all news always content non-proveable connections with kind of third-world countries. This is usually something which makes me very wondering as this is usually what all microcaps do if they want to publish great news - but it should not be possible to prove it. Not anything done by Plandai is either in the USA or in Europe - it is always in Africa and South-America - I would not wonder if the next news comes from Saudi-Arabia, India, Pakistan, Indonesia or Vietnam.
Sorry, but I have been in tons of microcpas whith exactly this kind of news releases. I know the next argument: As long as MJ is prohibited in the States things have to be done somewehere else in the world...sorry, old arguments, well known.
As long as Plandai does not publish revenues very close within coming 3 - 4 months - as long I do not give a dime on any news of this kind. And, as always since a years ,the market agrees with my arguments - unfortunately !!!!
http://finance.yahoo.com/news/plandai-biotechnology-cannabis-research-gets-140000013.html
"
Plandai Biotechnology Cannabis Research Gets Green Light From Uruguay
Marketwired
Plandai Biotechnology, Inc. 3 hours ago
NEW YORK, NY--(Marketwired - November 05, 2014) - Plandaí Biotechnology (PLPL) just became one of very few companies to receive a government sanction to grow cannabis for medical research. It was announced last week that Uruguay's Minister of Public Health has given Plandaí the go-ahead to collaborate with the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo.
This collaboration that will allow Plandaí, through its wholly owned subsidiary Plandaí Biotechnology - Uruguay, SA, to grow cannabis in conjunction with the University of the Republic, for medical research, which will be conducted by students and scientists from the School of Science at the University.
While some U.S. states have given licenses to conduct cannabis research, under federal law growing marijuana, for any purposes, is still illegal. This, of course, has limited research into the possible medical benefits of cannabis which lends even more significance to Plandaí's collaboration in Uruguay. The approval was issued this past September, and it is scheduled to take place over a 3-year period beginning in early 2015.
With the federal government in Uruguay giving Plandaí the green light, the company can now legally grow cannabis, and not just CBD dominant strains either, and then begin clinical testing using the drug. The first phase of the project will establish the infrastructure and protocols for growing the cannabis in a controlled environment to ensure genetic purity and chemical consistency.
When asked about controlling the environment in which the cannabis will be grown, Plandaí Biotechnology CEO Roger Duffield said, "Because the plant itself is so sensitive to environmental inputs, we will be constructing an indoor controlled growth facility where we can manage temperature, air pressure, light, nutrition, and genetics to ensure that we have consistency in our chemical profile, which is critical for future clinical trials."
The CEO says he expects it will take approximately 12 months for the facility to be installed and the first extract prepared for testing. Under this collaboration, Plandaí will for the first time be able to test marijuana for medicinal properties, and it also affords the company the chance to provide a pure chemical extract for third party testing. Duffield said the research will enable clinicians to set dosage parameters as well since, with clinical testing, Plandaí will have benchmarks for absorption and metabolization similar to that established with its green tea extract.
The CEO added, "There is currently so much variation in potency and chemical composition—even within the same strain of plant—that it is nearly impossible to determine what level of dosage is needed for clinical result. Our scientific approach should pave the way for greater understanding of the medicinal benefits of the plant."
After the first phase, a team of academics at the University of the Republic will then collaborate with Plandaí's scientists to test the cannabinoid complex for potential benefit for treating neuron disorders, cancers and concussion injuries through animal testing. However, before the Company can conduct human clinical trials, further approval from Uruguay's Ethics Committee and Medicine Council will be required.
"...The CEO says he expects it will take approximately 12 months for the facility to be installed and the first extract prepared for testing. ..."
Me, a shareholder says "Another (also approximately only - so could be 1.5 years and more)year only for installing facilities! ... Well, my take: Bye Bye shareprice"
Plandai is a big-mouth-company meanwhile in my opinion. Vision? Garbage! Getting annoyed about all those endless promises without any tiny sign of revenues.
BTW who is going to finance additional facilities ? Endless loans? Endless debt? Shareholder by dilution?`As I said, bye bye shareprice. This story is on the way to become one of those stocks which never delivers anything but words. Well know by microcap speculators. Poor.
If PLPL does not move its a§§ soon, election will not help at all. It is anyway a pity that always other reasons have to help to keep the strockprice up - Plandai does not deliver and does not annouce delivery - and this is real poor fact until today after two years.
I do not want 5% up on election , down again next day - I want 5% up on real business news followed by a growing confidence in the stock and steady increase of the shareprice. Until today everything is absolutely garbage by PLPL.
Do you really take such exxegerated prediction serious? I hope PLPL gets back to 1.00 - a market cap of 125.000.000 which is exxegerated as well. Thats all I hope for to get out again. I should have done this some months before. PLPL lives by to much phantasy - any wrong direction and the phantasy building cracks.
you should not take posts here serious - as no CEO in the world does LOL I have been told by many CEOs reading postgs is a wáste of time. I agree - posting is just fun for tiny shareholder
for some everything seems to be right whatever this strange stock does LOL Well, sorry, nut 5.00 is total nonsense, products of PLPL - if ever come to existence - never will be worth a marketcap of $600.000.000 - based on O/S 125.000.000 (hope dilution will not destroy this also)
I believe we will have first sales in summer 2015 - not before. For sure as I believe there will be new delays in the fields, in machines, in partners, in financial reports, in loans, in debt, in missing investments, in paper works, in clinical studies etc.etc.etc IMO
REMEMBER MY WORDS in summer 2015 !
SEC will shut this stock down soon for sure: Read this:
http://www.usatoday.com/story/money/markets/2013/06/03/sec-shell-company-stock/2384451/:
SEC raging war against empty shell companies
"Trading in 61 stocks described as "empty shells" was shut down Monday, as part of regulators' aggressive plan to sweep away dormant stocks often targeted by fraudsters.
Shutting down trading in thinly traded stocks has been a priority of the SEC for years. These stocks, which have next to no market value, can be easily bought by pump-and-dump operators who use them as a platform to lure in investors with false information.
This latest sweep is the largest since last year's "Operation Shell Expel" move by the SEC, which it removed a record 379 companies from trading in one trading day.
The move by the SEC is part of a trend at the regulator to use computers and data mining to help identify areas that are ripe for market manipulation before the fraud actually occurs, potentially saving investors from being separated from their money.
Shell companies are often bought by stock scammers for very little money. The names of the shell companies can then be changed into something that reflects a current hot theme with individual investors. The scammers can then buy up the stock for next to nothing, spread misleading and false press releases and then sell at higher stock prices.
While the action Monday was the biggest of the year so far, the SEC has been routinely been shutting down trading in shells all year.
"Stock manipulators crave empty shell companies that they can use to conduct pump-and-dump schemes and line their pockets with illicit trading profits by taking advantage of unsuspecting investors," says Andrew J. Ceresney, Co-Director of the SEC's Division of Enforcement in a statement. "We will aggressively suspend trading in such empty shells to take away a tool of their trade and help rid our markets of fraud."
AND HILLARD HERZOG IS STILL NO IN JAIL ! What a poor system of justice.
Partly I agree, but not in "They are not your typical non existent Penny stock company they are getting real recognition for their work" - Until now we have seen a pic of parts of a non-producing facility at Africa and some tea plants - which could come from wherever - and some informations about medical trials by unknown doctors from, somewhere in the world. I know a lot of listed penny stocks, which deliver the same informations about other products they might work on. But 'visible' is nothing, either at those stock nor at Plandai - as long as they have not been able to prove by official financial reports that the company is running .... by profits made by the products of this company and by partners who sell this company to the world! Yes, this is phantasy .... but not 'visible' !
The ONLY thing visible for me(!) is the fact that Shively, an ex-director of Microsft, got Vice President. This is the most promising part of PLPL - until today.. The rest are just words by Duffield and a stock promoter... and, yes, a dream of microcap pennyplayers - me included.
SNAP... and PLPL has a subsidary at Uruguay ...without any news release. Shareholder do not seems to be worth to receive such news.... they just receive it by a stock promoter. This has nothing to do with respect for shareholderr - and it smells bad as we receive always some informations here and some there withouit anything concrete or a tangible result of business. Just promises about something not visivble in foreign countries which can not be proved at all.
I know this kind of pennystock politics - and the stockmarket obvioulsy also.....not thrilled as I see.
Well, it might be right that such negative statements in 10k are in the interest of SEC and imn the interest of a management, which prefers to suck shareholder in the opposit in creatin shareholder value. but it is very obvious, that Plandai is NOT able to make any positve statement as there is nothing positive to state! I have been reading tons of 10k within last two decades - and many of start ups wrote about new partners - if their efforts have been noticed by companies who started a partnership - also the positive development of a product has been discript etc.etc.
Plandai obvioulsy has nothing to state in this direction, as well as their vice president states nothing. In my opinion a very poor behaviour after two years - just their promoter repeats endless the great development in cancer, viagra competition etc. - but I don't read anything about this in officil papers of Plandai !
Why? Because it is a difference to promise something in a news release - which could fail - in the opposite to state something inb a document which is readed by the SEC !
This is my take about this strange 10ks of PLPL.
Howeve, I believe we will see another hype for soem days, driving the stockprice north - but I don not believe in those multi-millions of revenues by Plandai as they even do not get their tea extract on the road, neither their extract method will not thrill the biotech market in my opinion. A promisingbiotech story is differenbt to a story like Plandai - it is simply to harmless to be a ten-bagger.
As always, IMHO !
IMO this is speculation on revenue phantasies 4th quarter. Some people like to avoid to miss a train of one of the more interesting penny plays at OTC - which PLPL still is of course.
If Plandai would be able to deliver ANY real good news (until now IMO only blahbah), of course the stock would rock. This is what some might believe and load now.
end of october 2014 - still no news about sales, partners, revenues or anything else regarding a REAL going business. Remember: Plandai promised revenues in 2012 already. Well, I don't know how long optimism shall keep at a pennystock like this. If this would not be the board of PLPL, I am sure we would have a big number of critical poster here who would called PLPL a 'scam'. I call it smelling unpleased more and more. This can not be called harmless 'delays' anymore !
Development stage stock - especially after aersy of delays of any reveneues and endless dept - usually do not show such mc. The reason why this mc is accepted by so many sdhareholder is just the fact that PLPL is a biotech-stock (which it isn't imo) and because Shively is involved. Just those reasons 'justify' (not) such a mc.
However, we have a different standpoint, which is ok. But IMO hopes in Plandai until now is not worth more than 15 - 20 million. This is how this kind of high risk pennystock in this stage of development are usually valued - and even lower !
By the way, development stage stocks can be found at NASDAQ as well ..... but many of them did delivery revenues already and nevertheless have a mc of same height as PLPL, but based on much lower OS.
I speculate on the fact, that many pennygambler believe in everything as long as they are part of a game. This hopes and phantasies are worth to be used by expereinced speculators. But it is true, who care whihc mc is right for PLPL as long as tons of dummies buy PLPL and make other rich.
The difference between the marketcap which is exxegareted at both stocks, Amazon and Plandai, is: Amazon is high because it has proved to be able to generate millions and billions of revenues. So the world wide stockmarket can trust in this story simply because Amazon management has done their job well. So mc is high, but stable since long!
Plandai did prove nothing at all until now because management delievered endless promises, delays in product, delay in sales, delay in winning partners, delay in revenues, missing investor relation and management has a 'problematic' reputation (excluded maybe Shively - even I do not know anything about the funcrtion and success of this ex-Microsoft director, just his hiphiphurry for legalizing MJ).
However, yes, worth a speculation, but for sure not worth that high mc.
Plandai compared with Amazon? LOL Well, why not .... everything is allowed lol
too early for big hopes: Market reacts euphorical to a news release but still waits for real revenues. So one day hiphip hurray and next day down, this is trading on news but not trading on real progress of revenues. PLPL has to deliver and not to promise anymore. Based on this current marketcap is still enormous.
mamazing - still activitoes here LOL By the way, is Herzog in jail finally? Still waiting for the right post about justice.